Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,100 INR | -0.34% | +0.36% | +5.93% |
May. 16 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 | |
May. 16 | Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.93% | 10.14B | |
+37.74% | 723B | |
+34.69% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.17% | 244B | |
+10.06% | 208B | |
-4.05% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- MANKIND Stock
- News Mankind Pharma Limited
- Jefferies Adjusts Mankind Pharma's Price Target to INR1,870 From INR1,830, Keeps at Hold